Skip to main content
SpringerLink
Log in

Esophageal cancer

  • Chapter
Book cover Gastrointestinal Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 98))

Abstract

Histopathologic examination allows classification of the malignant tumors that involve tne esophagus into four categories: 1) epithelial tumors, 2) metastatic tumors, 3) lymphomas, and 4) sarcomas [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Heitmiller RF, Forastiere AA. 1995. Esophagus. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds), Clinical Oncology. Churchill Livingstone: New York, p 1189.

    Google Scholar 

  2. Attah EB, Haijdu SI. 1968. Benign and malignant tumors of the esophagus at autopsy. J Thorac Cardiovasc Surg 55:396–404.

    PubMed  CAS  Google Scholar 

  3. Turnbull AD, Rosen P, Goodner JT, Beattie EJ. 1973. Primary malignant tumors of the esophagus other than typical epidermoid carcinoma. Ann Thorac Surg 15:463–473.

    PubMed  CAS  Google Scholar 

  4. Yang PC, Davis S. 1987. Incidence of cancer of the esophagus in the US by histologic type. Cancer 61:612–617.

    Google Scholar 

  5. Postlethwaite RW. 1986. Squamous cell carcinoma of the esophagus. In: Surgery of the Esophagus, 2nd ed. Appleton-Century-Crofts: Norwalk, CT, p 369.

    Google Scholar 

  6. Xu L, Sun C, Wu LH, Chang ZR, Liu T. 1984. Clinical and pathological characteristics of carcinosarcoma of the esophagus: report of four cases. Ann Thorac Surg 37:197–203.

    PubMed  CAS  Google Scholar 

  7. Ming S. 1992. Adenocarcinoma and other epithelial tumors of the esophagus. In: Ming S, Goldman H (eds), Pathology of the Gastrointestinal Tract. WB Saunders: Philadelphia, p459.

    Google Scholar 

  8. Epstein JI, Sears DL, Tucker RS, Eagan JW. 1982. Carcinoma of the esophagus with adenoid cystic differentiation. Cancer 53:1131–1136.

    Google Scholar 

  9. Bell-Thompson J, Haggitt RC, Ellis FH Jr. 1980. Mucoepidermoid and adenoid cystic carcinomas of the esophagus. J Thorac Cardiovasc Surg, 79:438–446.

    Google Scholar 

  10. Faintuch J, Shephard KV, Levin B. 1984. Adenocarcinoma and other unusual variants of esophageal cancer. Semin Oncol 11:196–202.

    PubMed  CAS  Google Scholar 

  11. Briggs JC, Ibrahim NBN. 1983. Oat cell carcinoma of the oesophagus: a clinico-pathological study of 23 cases. Histopathology 7:261–277.

    PubMed  CAS  Google Scholar 

  12. Law SY, Fok M, Lam KY, Loke SL, Ma LT, Wong J. 1994. Small cell cancer of the esophagus. Cancer 73:2894–2899.

    PubMed  CAS  Google Scholar 

  13. Ibrahim NBN, Briggs JC, Corshibley CM. 1984. Extrapulmonary oat cell carcinoma. Cancer 54:1645–1661.

    PubMed  CAS  Google Scholar 

  14. Roth JA, Lichter AS, Putnam JB Jr, Forastiere AA. 1993. Cancer of the esophagus. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds), Cancer: Principles and Practice of Oncology. J. B. Lippincott: Philadelphia, pp 776–817.

    Google Scholar 

  15. Worgan D, Baidock CR. 1976. Lymphosarcoma of the esophagus. J Laryngol Otol 90:207–210.

    PubMed  CAS  Google Scholar 

  16. Berman MD, Faichuk KR, Trey C, Gramm HF. 1979. Primary histiocytic lymphoma of the esophagus. Digest Dis Sci 24:883–886.

    PubMed  CAS  Google Scholar 

  17. Matsura H, Saito R, Nakajima S, Yoshihara W, Enomoto T. 1985. Non-Hodgkin’s lymphoma of the esophagus. Am J Gastroenterol 80:941–946.

    Google Scholar 

  18. Brady LW, Asbell SO. 1979. Malignant lymphoma of the gastrointestinal tract. Erskine Memorial Lecture. Radiology 137:291–298.

    Google Scholar 

  19. Bernai A, del Junco GW. 1986. Endoscopic and pathologic features of esophageal lymphoma: a report of four cases in patients with acquired immune deficiency syndrome. Gastroenterol Endocrinol 32:96–99.

    Google Scholar 

  20. Choh JH, Khzei AH, Ihm HJ. 1986. Leiomyosarcoma of the esophagus: report of a case and review of the literature. J Surg Oncol 32:223–229.

    PubMed  CAS  Google Scholar 

  21. Welch K, Finkbeiner W, Alpers CE, Blumenfield W, Davis RL, Smuckler EA, Beckstead JH. 1984. Autopsy findings in the acquired immune deficiency syndrome. JAMA 252:1152–1159.

    PubMed  CAS  Google Scholar 

  22. Gelb A, Miller S. 1986. AIDS and gastroenterology. Am J Gastroenterol 81:619–622.

    PubMed  CAS  Google Scholar 

  23. Parkin DM, Pisani P, Ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606.

    PubMed  CAS  Google Scholar 

  24. Blot WJ. 1994. Esophageal cancer trends and risk factors. Semin Oncol 21:403–410.

    PubMed  CAS  Google Scholar 

  25. Day NE, Varghese C. 1994. Oesophageal cancer. Cancer Surveys 19/20:43–54.

    Google Scholar 

  26. Pisani P, Parkin DM, Ferlay J. 1993. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55:891–903.

    PubMed  CAS  Google Scholar 

  27. Parker SL, Tong T, Bolden S, Wingo PA. 1996. Cancer statistics, 1996. CA Cancer J Clin 46:5–27.

    PubMed  CAS  Google Scholar 

  28. Macfarlane GJ, Plesko I, Kramarova E, Obsitnikova A, Boyle P. 1994. Epidemiologic features of gastric and oesophageal cancers in Slovakia. Br J Cancer 70:177–179.

    PubMed  CAS  Google Scholar 

  29. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Benichou J, Dai Q, Fraumeni JF Jr. 1994. Risk factors for esophageal cancer in Shanghai, China, I. Role of cigarette smoking and alcohol drinking. Int J Cancer 58:192–196.

    PubMed  CAS  Google Scholar 

  30. Parkin DM, Pisani P, Lopez AD, Masuyer E. 1994. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 59:494–504.

    PubMed  CAS  Google Scholar 

  31. Franceschi S, Talamini R, Barra S, Baron AE, Negri E, Bidoli E, Serraino D, La Vecchia C. 1990. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in Northern Italy. Cancer Res 50:6502–6507.

    PubMed  CAS  Google Scholar 

  32. Choi SY, Kahyo H. 1991. Effect of cigarette smoking and alcohol consumption in the etiology of cancer of the digestive tract. Int J Cancer 49:381–386.

    PubMed  CAS  Google Scholar 

  33. Tavani A, Negri E, Franceschi S, La Vecchia C. 1993. Risk factors for esophageal cancer in women in northern Italy. Cancer 72:2531–2536.

    PubMed  CAS  Google Scholar 

  34. Brown LM, Hoover RN, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, Liff JM, Silverman DT, Hayes RB, Pottern LM. 1994. Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J Natl Cancer Inst 86:1340–1345.

    PubMed  CAS  Google Scholar 

  35. Vaughn TL, Davis S, Kristal A, Thomas DB. 1995. Obesity, alcohol, and tobacco as risk factors for cancer of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Bio Prev 4:85–92.

    Google Scholar 

  36. Appleqvist P, Salmo M. 1979. Lye corrosion carcinoma of the esophagus. A review of 63 cases. Cancer 45:2655–2658.

    Google Scholar 

  37. Hopkins RA, Postlethwait RW. 1991. Caustic burns and carcinoma of the esophagus. Ann Surg 194:146–148.

    Google Scholar 

  38. Ghadirian P, Ekoe JM, Thouez JP. 1992. Food habits and esophageal cancer: an overview. Cancer Detect Prev 16:163–168.

    PubMed  CAS  Google Scholar 

  39. De Stefani E, Muñoz N, Estève J, Vasallo A, Victora CG, Teuchman S. 1990. Mate drinking, alcohol, tobacco, diet, and esophageal cancer in Uruguay. Cancer Res 50:426–431.

    PubMed  Google Scholar 

  40. Gao YT, McLaughlin JK, Gridley G, Blot WJ, Ji BT, Dai Q, Fraumeni JF Jr. 1994. Risk factors for esophageal cancer in Shanghai, China. II. Role of diet and nutrients. Int J Cancer 58:197–202.

    PubMed  CAS  Google Scholar 

  41. Hu J, Nyrén O, Wolk A, Bergstrom R, Yuen J, Adami HO, Guo L, Li H, Huang G, Xu X, Zhao F, Wang C, Qin H, Hu C, Li Y. 1994. Risk factors for oesophageal cancer in northeast China. Int J Cancer 57:38–46.

    PubMed  CAS  Google Scholar 

  42. Chu FS, Li GY. 1994. Simultaneous occurrence of fumonisin Bt and other mycotoxins in modly corn collected from People’s Republic of China in regions with high incidences of esophageal cancer. Appl Environ Microbiol 60:847–852.

    PubMed  CAS  Google Scholar 

  43. Fagge CH. 1872. Case of simple stenosis of oesophagus followed by epithelioma. Guy’s Hosp Rep 17:43.

    Google Scholar 

  44. Bolivar JC, Herendeen TL. 1970. Carcinoma of the esophagus and achalasia. Ann Thorac Surg 10:81–89.

    PubMed  CAS  Google Scholar 

  45. Sandler RS, Nyrén O, Ekbom A, Eisen GM, Yuen J, Josefsson S. 1995. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA 274:1359–1362.

    PubMed  CAS  Google Scholar 

  46. Iascone C, DeMeester TR, Little AG, Skinner DB. 1983. Barrett’s esophagus. Functional assessment, proposed pathogenesis and surgical therapy. Arch Surg 118:543–549.

    PubMed  CAS  Google Scholar 

  47. Cameron AJ, Ott BJ, Payne WS. 1985. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 313:857–859.

    PubMed  CAS  Google Scholar 

  48. Hamilton SR, Smith RRL, Cameron JL. 1988. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 19:942–948.

    PubMed  CAS  Google Scholar 

  49. Tytgat GN, Hameeteman W. 1992. The neoplastic potential of columnar-lined (Barrett’s) esophagus. World J Surg 16:308–312.

    PubMed  CAS  Google Scholar 

  50. Kalish RJ, Clancy PE, Orringer MB, Appelman HD. 1984. Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett’s esophageal mucosa and in the gastric cardia. Gastroenterology 86:461–467.

    PubMed  CAS  Google Scholar 

  51. Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG, Liff JM, Fraumeni JF Jr, Hoover RN. 1995. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87:104–109.

    PubMed  CAS  Google Scholar 

  52. Wang HH, Hsieh CC, Antolini DA. 1994. Rising incidence rate of esophageal adenocarcinoma and use of pharmacological agents which relax the lower esophageal sphincter (United States). Cancer Causes Control 5:573–578.

    PubMed  CAS  Google Scholar 

  53. Miwa K, Segawa M, Takano Y, Matsumoto H, Yagi M, Miyakzi I, Hatori T. 1994. Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer 70:185–189.

    PubMed  CAS  Google Scholar 

  54. Mirvish SS, Huang Q, Chen SC, Birt DF, Clark GW, Hinder RA, Smyrk TC, De Meester TR. 1993. Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal carcinoma in rats. Endoscopy 25:627–631.

    PubMed  CAS  Google Scholar 

  55. Rao M, Liu F-S, Dawsey SM, Yang K, Lipkin M, Li J-Y, Taylor PR, Li B, Blot WJ, Wang GO, Lewin KJ, Yu Y, Yang CS. Effects of vitamin/mineral supplementation on the proliferation of esophageal squamous epithelium in Linxian, China. Cancer Epidemiol Bio Prev 3:227–279.

    Google Scholar 

  56. Taylor PR, Li B, Dawsey SM, Li JY, Yang CS, Guo W, Blot WJ. 1994. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res 54:2029s–2031s.

    PubMed  CAS  Google Scholar 

  57. Wingo PA, Bolden S, Tong T, Parker SL, Martin LM, Heath CW Jr. 1996. CA Cancer J Clin 46:113–125.

    PubMed  CAS  Google Scholar 

  58. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. 1991. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287–1289.

    PubMed  CAS  Google Scholar 

  59. Macfarlane GJ, Boyle P. 1994. The epidemiology of oesophageal cancer in the UK and other European countries. J R Soc Med 87:334–337.

    PubMed  CAS  Google Scholar 

  60. Gray JR, Coldman AJ, MacDonald WC. 1992. Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus. Cancer 69:2227–2231.

    PubMed  CAS  Google Scholar 

  61. Brown LM, Silverman DT, Pottern LM, Schoenberg JB, Greenberg RS, Swanson GM, Liff JM, Scwartz AG, Hayes RB, Blot WJ, Hoover RN. 1994. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco and socioeconomic factors. Cancer Causes Control 5:333–340.

    PubMed  CAS  Google Scholar 

  62. Shibagaki I, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K. 1994. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res 54:2996–3000.

    PubMed  CAS  Google Scholar 

  63. Aoki T, Mori T, XiQun D, Nishihira T, Matsubara T, Nakamura Y. 1994. Alleotype study of esophageal carcinoma. Genes Chromosomes Cancer 10:177–182.

    PubMed  CAS  Google Scholar 

  64. Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Ishida K, Saito K, Satodate R. 1994. Aberrations of tumor suppressor genes (p53, ape, mcc, and Rb) in esophageal squamous cell carcinoma. Int J Cancer 57:21–25.

    PubMed  CAS  Google Scholar 

  65. Miyake S, Nagani K, Yoshino K, Oto M, Endo M, Yuasa Y. 1994. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinoma and their relation to metastasis. Cancer Res 54:3007–3010.

    PubMed  CAS  Google Scholar 

  66. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakmura Y. 1994. Frequent somatic mutations of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in squamous cell carcinoma. Cancer Res 54:3396–3397.

    PubMed  CAS  Google Scholar 

  67. Mori T, Aoki T, Matsubara T, Iida F, XiQun D, Nishihira T, Mori S, Nakamura Y. Frequent loss of heterozygosity in the region including BRCAl on chromosome 17q in squamous cell carcinoma of the esophagus. Cancer Res 54:1638–1640.

    Google Scholar 

  68. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ. 1996. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12:1873–1878.

    PubMed  CAS  Google Scholar 

  69. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC. 1990. Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 87:9958–9961.

    PubMed  CAS  Google Scholar 

  70. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. 1992. Wild-type p53 is a cell cyclecheckpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491–7495.

    PubMed  CAS  Google Scholar 

  71. Lane DP. 1993. A death in the life of p53. Nature 369:786–787.

    Google Scholar 

  72. Blount PL, Galipeu PC, Sanchez CA, Neshat K, Levine DS, Yin J, Suzuki H, Abraham JM, Meltzer SJ, Reid BJ. 17p allelic losses in aneuploid cell of patients with Barrett’s esophagus who develop aneuploidy. Cancer Res 54:2292–2295.

    Google Scholar 

  73. Hamelin R, Fléjou JF, Muzeau F, Potet F, Laurent-Puif P, Fékété F, Thomas G. 1994. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett’s esophagus. Gastroenterology 107:1012–1018.

    PubMed  CAS  Google Scholar 

  74. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS. 1994. p53 tumor suppressor gene mutations in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 54:4342–4346.

    PubMed  CAS  Google Scholar 

  75. Jaskewicz K, DeGroot KM. 1994. p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium. Anticancer Res 14:137–140.

    Google Scholar 

  76. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE. 1994. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74:2218–2223.

    PubMed  CAS  Google Scholar 

  77. Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S, Nagura H. 1994. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathological findings and DNA amplification. Cancer 74:795–804.

    PubMed  CAS  Google Scholar 

  78. Flejou JF, Paraf F, Muzeau F, Fékété F, Hénin D, Jothy S, Potet F. 1994. Expression of c-erbB-2 oncogene product in Barrett’s adenocarcinoma: pathological and prognostic correlations. J Clin Pathol 47:23–26.

    PubMed  CAS  Google Scholar 

  79. Sauter ER, Keller SM, Erner S, Goldberg M. 1993. HER-2/neu: a differentiation marker in adenocarcinoma of the esophagus. Cancer Lett 75:41–44.

    PubMed  CAS  Google Scholar 

  80. Shiga C, Shiga K, Hirayama K, Katayama M, Nishihira T, Mori S. 1994. Prognostic significance of hst-1 gene amplfication in primary esophageal carcinomas and its relationship to other prognostic factors. Anticancer Res 14:651–656.

    PubMed  CAS  Google Scholar 

  81. Younes M, Lebovitz RM, Lechago LV, Lechago J. 1993. p53 accumulation in Barrett’s metaplasia, dysplasia and carcinoma: a follow-up study. Gastroenterology 105:1637–1642.

    PubMed  CAS  Google Scholar 

  82. Rosen N. 1994. The molecular basis for cellular transformation: implications for esophageal carcinogenesis. Semin Oncol 21:416–424.

    PubMed  CAS  Google Scholar 

  83. Stemmerman G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA, Fenoglio-Preiser CM. 1994. The molecular biology of esophageal and gastric cancer and their precursors. Hum Pathol 25:968–981.

    Google Scholar 

  84. Winawer SJ. 1979. Screening for gastrointestinal cancer Front Gastrointest Res 5:35–43.

    PubMed  CAS  Google Scholar 

  85. Zornoza J, Lindell MM Jr. 1980. Radiologic evaluation of small esophageal carcinoma. Gastrointest Radiol 5:107–111.

    PubMed  CAS  Google Scholar 

  86. Halvorsen RA, Thompson WM. 1984. Computed tomographic evaluation of esophageal carcinoma. Semin Oncol 11:113–126.

    PubMed  CAS  Google Scholar 

  87. Thompson WM, Halvorsen RA Jr. 1994. Staging esophageal carcinoma II: CT and MRI. Semin Oncol 21:447–452.

    PubMed  CAS  Google Scholar 

  88. Qunit LE, Glazer GM, Orringer MB, Gross BH. 1985. Esophageal carcinoma, CT findings. Radiology 155:171–175.

    Google Scholar 

  89. Becker CD, Barbier P, Porcellini B. 1986. CT evaluation of patients undergoing transhiatal esophagectomy for cancer. J Comput Assist Tomogr 10:607–611.

    PubMed  CAS  Google Scholar 

  90. Hanson JT, Thoreson C, Morrissey JF. 1980. Brush cytology in the diagnosis of upper gastrointestinal malignancy. Gastrointest Endosc 26:33–35.

    PubMed  CAS  Google Scholar 

  91. Prolla JC, Reilly W, Kirsner JB, Cockerham L. 1977. Direct-vision endoscopic cytology and biopsy in the diagnosis of esophageal and gastric tumors: current experience. Acta Cytol 21:399–402.

    PubMed  CAS  Google Scholar 

  92. Winawer SJ, Sherlock P, Belladonna JA, Melamed M, Beattle EJ Jr. 1975. Endoscopic brush cytology in esophageal cancer. JAMA 232:1358.

    Google Scholar 

  93. Kobayashi S, Kasugai T. 1978. Brushing cytology for the diagnosis of gastric cancer involving the cardia or the lower esophagus. Acta Cytol 22:155–157.

    PubMed  CAS  Google Scholar 

  94. Lightdale CJ. 1994. Staging of esophageal cancer I: endoscopic sonography. Semin Oncol 21:438–446.

    PubMed  CAS  Google Scholar 

  95. Heintz A, Hohne U, Schweden F, Junginger T. 1991. Preoperative detection of intrathoracic tumor spread of esophageal cancer: endosonography versus computed tomography. Surg Endosc 5:75–78.

    PubMed  CAS  Google Scholar 

  96. Botet JF, Lightdale CJ, Zauber AG, Gerdes H, Urmacher C, Brennan MF. 1991. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 181:419–425.

    PubMed  CAS  Google Scholar 

  97. Peters JH, Hoeft SF, Heimbucher J, Brenner RM, DeMeester TR, Bremner CG, Clark GWB, Kiyabu M, Parisky Y. 1994. Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. Arch Surg 129:534–539.

    PubMed  CAS  Google Scholar 

  98. Shandall A, Johnson C. 1985. Laparoscopy or scanning in oesophageal and gastric carcinoma? Br J Surg 72:449–451.

    PubMed  CAS  Google Scholar 

  99. Watt I, Stewart I, Anderson D, Bell G, Anderson JR. 1989. Laparoscopy, ultrasound and computed tomorgraphy of the oesophagus and gastric cardia: a prospective comparison for detecting intra-abdominal metastases. Br J Surg 76:1036–1039.

    PubMed  CAS  Google Scholar 

  100. Molloy RG, McCourtney JS, Anderson JR. 1995. Laparoscopy in the management of patients with cancer of the gastric cardia and oesophagus. Br J Surg 82:352–354.

    PubMed  CAS  Google Scholar 

  101. Krasna MJ, Flowers JL, Attar S, McLaughlin J. 1996. Combined thoracoscopic/laparoscopic staging of esophageal cancer. J Thorac Cardiovasc Surg 111:800–807.

    PubMed  CAS  Google Scholar 

  102. American Joint Committee on Cancer. 1993. Esophagus. In Handbook for Staging of Cancer. JB Lippincott: Philadephia, pp 75–80.

    Google Scholar 

  103. Orringer MB. 1983. Esophageal carcinoma: what price palliation? Ann Thorac Surg 36:377–379.

    PubMed  CAS  Google Scholar 

  104. Roth JA, Putnam JB Jr. 1994. Surgery for cancer of the esophagus. Semin Oncol 21:453–461.

    PubMed  CAS  Google Scholar 

  105. Lewis I. 1946. The surgical treatment of carcinoma of the oesophagus. Br J Surg 34:18–31.

    PubMed  CAS  Google Scholar 

  106. Lozac’h P, Topart P, Etienne J, Charles JF. 1991. Ivor Lewis operation for epidermoid carcinoma of the esophagus. Ann Thorac Surg 52:1154–1157.

    CAS  Google Scholar 

  107. LeQuesne LP, Ranger D. 1966. Pharyngolaryngectomy with immediate pharyngogastric anastomosis. Br J Surg 53:105–109.

    CAS  Google Scholar 

  108. Shahian DM, Neptune WB, Ellis FH, Watkins E Jr. 1986. Transthoracic versus extrathoracic esophagectomy. Ann Thorac Surg 41:237–246.

    PubMed  CAS  Google Scholar 

  109. Bolton JS, Ochsner JL, Abdoh AA. 1994. Surgical management of esophageal cancer. Ann Surg 5:475–480.

    Google Scholar 

  110. Shriver CD, Burt M. 1992. Transhiatal esophagectomy. Semin Thorac Cardiovasc Surg 4:307–313.

    PubMed  CAS  Google Scholar 

  111. Heitmiller RF, Jones B. 1991. Transient diminished airway protection after transhiatal esophagectomy. Am J Surg 162:442–446.

    PubMed  CAS  Google Scholar 

  112. Orringer MB, Forastiere AA, Perez-Tamayo C, Urba S, Takasugi BJ, Bromberg J. 1990. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg 49:348–355.

    PubMed  CAS  Google Scholar 

  113. McKeown, KC. 1976. Total three-stage oesophagectomy for cancer of the esophagus. Br J Surg 63:259–262.

    PubMed  CAS  Google Scholar 

  114. Heitmiller RF. 1988. The left thoracoabdominal incision. Ann Thorac Surg 46:250–253.

    PubMed  CAS  Google Scholar 

  115. Pradhan GN, Eng JB, Sabanathan S. 1989. Left thoracotomy approach for resection of carcinoma of the esophagus. Surg Gynecol Obstet 168:49–53.

    PubMed  CAS  Google Scholar 

  116. Page RD, Khalil JF, Whyte RI, Kaplan DK, Donnelly RJ. 1990. Esophagogastrectomy via left thoracophrenotomy. Ann Thorac Surg 49:763–766.

    PubMed  CAS  Google Scholar 

  117. van Lanschot JJB, Tilanus HW, Voormolen MHJ, van Deelen RAJ. 1994. Recurrence pattern of oesophageal carcinoma after limited resection does not support wide local excision with extensive lymph node dissection. Br J Surg 81:1320–1323.

    PubMed  Google Scholar 

  118. Skinner DB. 1983. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 85:59–71.

    PubMed  CAS  Google Scholar 

  119. Altorki NK, Skinner DB. En bloc esophagectomy: the first 100 patients. Hepatogastroenterology 37:360–363.

    Google Scholar 

  120. DeMeester TR, Zaninotto G, Johansson KE. 1988. Selective therapeutic approach to cancer of the lower esophagus and cardia. J Thorac Cardiovasc Surg 95:42–54.

    PubMed  CAS  Google Scholar 

  121. Sugimachi K, Watanabe M, Sadanaga N, Ikebe M, Kiamura K, Mori M, Kuwno H. 1994. Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg 178:363–368.

    PubMed  CAS  Google Scholar 

  122. Kato H, Tachimori Y, Mizobuchi S, Igaki H, Ochiai A. 1993. Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus. Cancer 72:2879–2882.

    PubMed  CAS  Google Scholar 

  123. Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, Akazawa K. 1994. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 219:310–316.

    PubMed  CAS  Google Scholar 

  124. Goldfaden D, Orringer MB, Appelman HD, Kalish R. 1986. Adenocarcinoma of the distal esophagus and gastric cardia. J Thorac Cardiovasc Surg 91:242–247.

    PubMed  CAS  Google Scholar 

  125. Hankins JR, Attar S, Coughlin TR Jr, Miller JE, Hebel JR, Suter CM, McLaughlin JS. 1987. Carcinoma of the esophagus: a comparison of the results of transhiatal versus transthoracic resection. Ann Thorac Surg 47:700–705.

    Google Scholar 

  126. Fok M, Siu KF, Wong J. 1989. A comparison of transhiatal and transthoracic resection for carcinoma of the thoracic esophagus. Am J Surg 158:414–419.

    PubMed  CAS  Google Scholar 

  127. Ellis FH. 1989. Treatment of carcionoma of the esophagus or cardia. Mayo Clin Proc 64:945–955.

    PubMed  Google Scholar 

  128. Fahn HJ, Wang LS, Huang BS, Huang MS, Chien KY. 1994. Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg 57:669–676.

    Google Scholar 

  129. Mantravardi RV, Lad T, Briele H, Liebner EJ. 1982. Carcinoma of the esophagus: sites of failure. Int J Radiat Oncol Biol Phys 8:1897–1901.

    Google Scholar 

  130. Flores A, Nelems B, Evans K, Evans K, Hay JH, Stoller J, Jackson SM. 1989. Impact of new radiotherapy modalities on the surgical management of cancer of the esophagus and cardia. Int J Radiat Oncol Biol Phys 22:937–944.

    Google Scholar 

  131. Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T. 1991. High-dose rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogog College of Medicine. Radiother Oncol 23:107–114.

    Google Scholar 

  132. Sur RK, Dip NB, Singh DP, Dharma SC, Singh MT, Kochhar R, Negi PS, Sethi T, Patel F, Ayyagari S, Bhatia SPS, Gupta BD. 1991. Radiation therapy of esophageal cancer: role of high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 22:143–146.

    Google Scholar 

  133. Smalley SR, Gunderson LL, Reddy EK, Williamson S. 1994. Radiotherapy alone in esophageal carcinoma: current management and future directions of adjuvant, curative and palliative approaches. Semin Oncol 21:467–473.

    PubMed  CAS  Google Scholar 

  134. Earle JD, Gelber RD, Moertel CG, Hahn RG. 1980. A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 6:821–826.

    PubMed  CAS  Google Scholar 

  135. Van Andel JG, Dees J, Dijkhuis CM, Fokkens W, van Houten H, de Jong PC, van Woerkom-Eyekenboom WMH. 1979. Carcinoma of the esophagus: results of treatment. Ann Surg 190:684.

    PubMed  Google Scholar 

  136. Newaishy GA, Read GA, Duncan W, Kerr GR. 1982. Results of radical radiotherapy of squamous cell carcinoma of the oesophagus. Clin Radiol 33:347.

    PubMed  CAS  Google Scholar 

  137. Beatty JD, DeBoer G, Rider WD. 1987. Carcinoma of the esophagus. Cancer 43:2254–2267.

    Google Scholar 

  138. Okawa T, Kita M, Tanaka M, Ikeda M. 1989. Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 17:49–54.

    Google Scholar 

  139. De-Ren S. 1989. Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int J Radiat Oncol Biol Phys 16:329–334.

    Google Scholar 

  140. Jun W, Gao SZ, Guo BZ. 1992. Study of radiation dosage in esophageal carcinoma. China Med J 105:132–134.

    Google Scholar 

  141. Jun W, Guo BZ, Gao SZ. 1991. Accelerated hyperfractionation radiotherapy in eosphageal cancer: an analysis of 172 cases. China Med J 104:228–229.

    Google Scholar 

  142. O’Rourke IC, Tiver K, Bull C, Gebski V, Langlands AO. 1988. Swallowing performance after radiation therapy for carcinoma of the esophagus. Cancer 61:2022–2026.

    Google Scholar 

  143. Elkon D, Lee M-S, Hendrickson FR. 1978. Carcinoma of the esophagus: sites of recurrence and palliative benefits after definitive radiotherapy. Int J Radiat Oncol Biol Phys 4:615–620.

    Google Scholar 

  144. Gignoux M, Roussel A, Palliot B, Gillet M, Schlag P, Favre JP, Dalesio O, Buyse M, Duez N. 1987. The value of preoperative radiotherapy in esophageal cancer: results of a study of the EORTC. World J Surg 11:426–432.

    Google Scholar 

  145. Launois B, Delarue D, Campion JP, Kerbaol M. 1981. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153:690–692.

    Google Scholar 

  146. Wang M, Gu X-Z, Yin W, Huang G, Wang L-J, Zhang D-W. 1989. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16:325–327.

    Google Scholar 

  147. Arnott SJ, Duncan W, Kerr GR, Walbaum PR, Cameron E, Jack WJL, Mackillop WJ. 1992. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24:108–113.

    Google Scholar 

  148. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, Mantyla M, Modig H, Munck-Wikland E, Rosengren B, et al. 1992. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16:1104–1109.

    Google Scholar 

  149. Teniere P, Hay JM, Fingerhut A, Fagniez PL. 1991. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicentre controlled trial. Gynecol Obstet 173:123–130.

    Google Scholar 

  150. Fok M, Sham JST, Choy D, Cheng SWK, Wong J. 1993. Postoperative radiotherapy for carcinoma of the esophagus: a prospective randomized controlled study. Surgery 113:138–147.

    Google Scholar 

  151. Ajani JA. 1994. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 21:474–482.

    Google Scholar 

  152. Forastiere AA.

    Google Scholar 

  153. Lockich JJ, Shea M, Chaffey J. 1987. Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer 60:275–279.

    Google Scholar 

  154. Ezdinli EZ, Gelber R, Desai DV, Falkson G, Moertel CG, Hahn RG. 1980. Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience. Cancer 46:2149–2153.

    Google Scholar 

  155. Engstrom PF, Lavin PT, Klaassen DJ. 1983. Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat Rep 731–745.

    Google Scholar 

  156. Davis S, Shanmugathasa M, Kessler W. 1980. Cis-dichlorodiammine platinum (II) in the treatment of esophageal carcinoma. Cancer Treat Rep 64:709–711.

    Google Scholar 

  157. Ravry M, Moore M. 1980. Phase II pilot study of cisplatin (II) in advanced squamous cell esophageal cancer. Proc Am Soc Clin Oncol 21:353.

    Google Scholar 

  158. Panettiere FJ, Leichman LP, Tilchen EJ, Chen TT. 1984. Chemotherapy for advanced epidermoid carcinoma of the esophagus with single agent cisplatin: final report on Southwest Oncology Group Study. Cancer Treat Rep 68:1023–1024.

    Google Scholar 

  159. Bleiberg H, Jacob J, Bedenne L, Paillot B, De Besi P, Lacave A. 1991. Randomized phase II trial of 5-fluorouracil (5-FU) and cisplatin (DDP) versus DDP alone in advanced esophageal cancer. Proc Am Soc Clin Oncol 10:145.

    Google Scholar 

  160. Advani SH, Saikia TK, Swaroop S, Ramakrishnan G, Nair CN, Dinshaw KA, Sharma S, Vyas JJ, Desai PB. 1985. Anterior chemotherapy in esophageal cancer. Cancer 56:1502–1506.

    Google Scholar 

  161. Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP. 1994. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86:1086–1091.

    Google Scholar 

  162. Whittington R, Close H. 1970. Clinical experience with mitomycin C. Cancer Chemother Rep 54:195–198.

    Google Scholar 

  163. Kelsen DP, Bains MS, Cvitkovic E, Golbey R. 1979. Vindesine in the treatment of esophageal carcinoma: a phase II study. Cancer Treat Rep 63:2019–2021.

    PubMed  CAS  Google Scholar 

  164. Bedikian AY, Valdivieso M, Bodey GP, Freireich EJ. 1979. Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors. Cancer Chemother Pharmacol 2:263–265.

    PubMed  CAS  Google Scholar 

  165. Bezwoda WR, Derman DP, Weaving A, Nissenbaum M. 1984. Treatment of esophageal cancer with vindesine: an open trial. Cancer Treat Rep 64:783–785.

    Google Scholar 

  166. Kelsen DP, Chapman R, Bains M, Heelan R, Dukeman M, Golbey R. 1982. Phase II study of methyl-GAG in the present treatment of esophageal carcinoma. Cancer Treat Rep 66:1427–1429.

    PubMed  CAS  Google Scholar 

  167. Ravry MJR, Omura GA, Hill GJ, Bartolucci AA, Velez-Garcia E. 1986. Phase II evaluation of mitoguazone in cancer of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group trial. Cancer Treat Rep 70:533–534.

    PubMed  CAS  Google Scholar 

  168. Falskon G. 1971. Methyl-GAG (NSC 32946) in the treatment of esophageal cancer. Cancer Chemother Rep 55:209–212.

    Google Scholar 

  169. Conroy TC, Etienne PL, Adenis A, Wagener DJ, Paillot B, Francois E, Bedenne L, Jacob JH, Seitz JF, Bleiberg H, Van pottelsberghe C, Van Glabbeke M, Delgado FM, Merle S, Wils J. 1996. Phase II trial of vinorelbine in metastatic squamous cell carcinoma. J Clin Oncol 14:164–170.

    PubMed  CAS  Google Scholar 

  170. Kolarcic K, Maricic Z, Roth A, Dujmovic I. 1980. Combination of bleomycin and adriamycin with and without radiation in the treatment of inoperable esophageal cancer. Cancer 45:2265–2273.

    Google Scholar 

  171. Clinical Screening Group. 1970. Study of the clinical efficiency of bleomycin in human cancer. Br Med J 2:643.

    Google Scholar 

  172. Bonnadonna G, de Lena M, Monfardini S, Bartoli C, Bajetta E, Beretta G, Fossati-Bellani F. 1972. Clinical trial with bleomycin in lymphomas and solid tumors. Eur J Cancer Clin Oncol 8:205–215.

    Google Scholar 

  173. Yagoda A, Mukherji B, Young C, Etcubanas E, Lamonte C, Smith JR, Tan CTC, Krakoff. 1972. Bleomycin, an antitumor antibiotic: clinical experience in 274 patients. Ann Intern Med 77:861–870.

    PubMed  CAS  Google Scholar 

  174. Stephens FO. 1973. Bleomycin — a new approach in cancer chemotherapy. Med J Aust 1:1277–1283.

    PubMed  CAS  Google Scholar 

  175. Ravry M, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ. 1973. Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC 125066). Cancer Chemother Rep 57:493–495.

    PubMed  CAS  Google Scholar 

  176. Kolarcic K, Moricic Z, Dujmovic I, Roth A. 1976. Therapy of advanced esophageal cancer with bleomycin, irradiation and combination bleomycin and irradiation. Tumori 62:255–262.

    Google Scholar 

  177. Iizuka T, Kalegawa T, Ide H, Isono K, Takagi I, Fukushima M, Ando N, Watanabe H, Takayama W, Arimori M, Ishida K, Endo M. 1991. Phase II study of CDDP + 5-FU for squamous esophageal carcinoma: JEOG Co-operative Study results. Proc Am Soc Clin Oncol 10:157.

    Google Scholar 

  178. Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, Levin B, Mountain C. 1992. Prolonged chemotherapy for localised squmaous carcinoma of the oesophagus. Eur J Cancer 28A:880–884.

    PubMed  CAS  Google Scholar 

  179. Carey RW, Hilgenberg AD, Wilkins EW Jr, Choi NC, Mathisen DJ, Grillo HC, Wain JC, Logan DL, Bromberg C. 1993. Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest 11:99–105.

    PubMed  CAS  Google Scholar 

  180. Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB, Shields TW. 1987. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 60:2156–2160.

    PubMed  CAS  Google Scholar 

  181. Wright CD, Mathisen JD, Wain JC, Grillo HC, Hilgenberg AD, Moncure AC, Carey RW, Choi NC, Daly M, Logan DL. 1994. Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction. Ann Thorac Surg 58:1574–1578.

    PubMed  CAS  Google Scholar 

  182. Ilson DH, Sirott, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP. 1995. A phase II trial of interferon alfa-2a, 5-fluorouracil, aand cisplatin inpatients with advanced esophageal carcinoma. Cancer 75:2197–2202.

    PubMed  CAS  Google Scholar 

  183. De Besi P, Sileni VC, Salvagno L, Tremolada C, Cartel G, Fosser V, Paccagnella A, Peracchia A, Fiorentino M. 1986. Phase II trial of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer. Cancer Treat Rep 70:909–910.

    PubMed  Google Scholar 

  184. Gisselbrecht C, Calvo F, Mignot L, Pujade E, Bouvry M, Danne O, Belpomme D, Marty M. 1983. Fluorouracil (F), adriamycin (A), and cisplatin (P) (FAP) combination chemotherapy of advanced esophageal carcinoma. Cancer 52:974–977.

    PubMed  CAS  Google Scholar 

  185. Ajani JA, Roth JA, Ryan B, McMurtrey M, Rich TA, Jackson DE, Abbruaaese JA, Levin B, CeCaro L, Mountain C. 1990. Evaluation of pre-and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 8:1231–1238.

    PubMed  CAS  Google Scholar 

  186. Stahl M, Wilke H, Meyer H-J, Preusser P, Berns T, Fink U, Achterrath W, Knipp H. Harstrick A, Berger M, Schmoll HJ. 1993. 5-fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. Eur J Cancer 30A:325–328.

    Google Scholar 

  187. Ajani JA, Ilson D, Bhalla K, Forastiere A, Pazdur R, Martin L, Daugherty K, Kelsen DP. 1995. Taxol©, cisplatin, and 5-FU (TCF): a multi-institutional phase II study in patients with carcinoma of the esophagus. Proc Am Soc Clin Oncol 14:203.

    Google Scholar 

  188. Coonley CJ, Bains M, Hilaris B, Chanpman R, Kelsen DP. 1983. Cisplatin and bleomycin in the treatment of esophageal carcinoma. A final report. Cancer 54:2351–2355.

    Google Scholar 

  189. Vogl SE, Greenwald E, Kaplan BH. 1980. Effective chemotherapy for esophageal cancer with methotrexate, bleomycin and cis-diamminedichloroplatinum II. Cancer 48:2555–2558.

    Google Scholar 

  190. DeBesi P, Slavagno L, Endrizzi L, Sileni VC, Fosser V, Cartei G, Pccagnella A, Pardo E, Tremolada C, Peracchia A, Fiorentino MV. 1984. Cisplatin, bleomycin, and methotrexate in the treatment of advanced oesophageal cancer. Eur J Cancer Clin Oncol 20:743–747.

    CAS  Google Scholar 

  191. Dinwoodie WR, Bartolucci AA, Lyman GH, Velz-Garcia E, Martelo OJ, Sarma PR. Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group trial. Cancer Treat Rep 70:267–270.

    Google Scholar 

  192. Schlag P, Herrmann R, Raeth V, Lehner B, Schwarz V, Herfarth C. 1988. Preoperative chemotherapy in esophageal cancer. A phase II study. Acta Oncologica 27:811–814.

    PubMed  CAS  Google Scholar 

  193. Kelsen D, Hilaris B, Coonley C, Lesser M, Dukeman M, Heelan R, Bains M. 1983. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med 75:645–652.

    PubMed  CAS  Google Scholar 

  194. Kelsen DP, Fein R, Coonley C, Heelan R, Bains M. 1986. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer. Cancer Treat Rep 70:255–259.

    PubMed  CAS  Google Scholar 

  195. Forastiere AA, Gennis M, Orringer MB, Agha FP. 1987. Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus. J Clin Oncol 5:1143–1149.

    PubMed  CAS  Google Scholar 

  196. Chapman R, Fleming TR, Van Damme J, Macdonald J. 1987. Cisplatin, vinblastine, and mitoguazone in squamous cell carcinoma of the esophagus: a Southweast Oncology Group study. Cancer Treat Rep 71:1185–1187.

    PubMed  CAS  Google Scholar 

  197. Ajani JA, Roth JA, Ryan MB, Putnam JB, Pazdur R, Levin B, Gutterman JU, McMurtry M. 1993. Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 11:22–28.

    PubMed  CAS  Google Scholar 

  198. Mannell A, Winters Z. 1988. Carboplatin in the treatment of oesophageal cancer. S Afr J Med 76:213–214.

    Google Scholar 

  199. Lovett D, Kelsen D, Eiseenberger M, Houston C. 1991. A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus. Cancer 67;354–356.

    PubMed  CAS  Google Scholar 

  200. Roth JA, Pass HU, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. 1988. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96:242–248.

    PubMed  CAS  Google Scholar 

  201. Schlag PM. 1992. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg 127:1446–1450.

    PubMed  CAS  Google Scholar 

  202. Coia LR. 1994. Chemoradiation as primary management of esophageal cancer. Semin Oncol 21:483–492.

    PubMed  CAS  Google Scholar 

  203. Richmond J, Seydel HG, Bae Y, Lewis J, Burdakin J, Jacobsen G. 1987. Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys 13:1617–1620.

    PubMed  CAS  Google Scholar 

  204. Seitz J, Giovanni M, Padaut-Cesana J, Fuentes P, Giudicelli R, Gauthier AP, Carcassonne Y. 1990. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 66:214–219.

    PubMed  CAS  Google Scholar 

  205. Leichman L, Herskovic A, Leichman CG, Lattin PB, Steiger Z, Tapazoglou E, Rosenberg JC, Arbulu A, Asfaw I, Kinzie J. 1987. Nonoperative therapy for squamous cell cancer of the esophagus. J Clin Oncol 5:365–370.

    PubMed  CAS  Google Scholar 

  206. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. 1991. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 20:29–36.

    PubMed  CAS  Google Scholar 

  207. Chan A, Wong, Arthur K. 1988. Concomitant 5-fluorouracil infusion, mitomycin-C and radical therapy in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 16:59–65.

    Google Scholar 

  208. John MJ, Flam MS, Mowry PA, Podolsky WJ, Xavier AM, Wittlinger PS. 1989. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 63:2397–2403.

    PubMed  CAS  Google Scholar 

  209. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B. 1992. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598.

    PubMed  CAS  Google Scholar 

  210. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B. Submitted. Progress report of combined chemo-radiotherapy vs radiotherapy alone in patients with esophageal cancer. An Intergroup study (RTOG 8501, SWOG 8598, NCCTG 884051).

    Google Scholar 

  211. Sischy B, Ryan L, Haller D, Smith T, Dayal Y, Schutt A, Hinson J. 1990. Interim report of EST 1282 phase III protocol for the evaluation of combined modalities in the treatment of patients with carcinoma of the esophagus stage I and II. Proc Am Soc Clin Oncol 9:105.

    Google Scholar 

  212. Poplin E, Fleming T, Leichman L, Seydel HG, Steiger Z, Taylor S, Vance R, Stuckey WJ, Rivkin SE. 1987. Combined therapies for squamous cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 5:622–628.

    PubMed  CAS  Google Scholar 

  213. Seydel HG, Leichman L, Byhardt R, Cooper J, Herskovic A, Libnock J, Pazdur R, Speyer J, Tschan J, and the RTOG. 1988. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: A RTOG study. Int J Radiat Oncol Biol Phys 14:33–35.

    PubMed  CAS  Google Scholar 

  214. Forastiere AA, Orringer MB, Prez-Tamayo C, Urba SG, Zahurak M. 1993. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report.

    Google Scholar 

  215. Forastiere AA, Heitmiller RF, Lee DJ, Abrams R, Miller D, Kleinberg L, Watkins S, Yeo C, Lillemoe K, Sitzmann, Sharfmann W, Zahurak M. Submitted. Brief intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.

    Google Scholar 

  216. Stahl M, Wilke H, Fink U, Stuschke M, Walz MK, Siewert JR, Molls M, Fett W, Makoski H-B, Breuer N, Schmidt U, Niebel W, Sack H, Eigler FW, Seeber S. 1996. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J Clin Oncol 14:829–837.

    PubMed  CAS  Google Scholar 

  217. Sauter E, Coia L, Keller S. 1993. Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction. Ann Surg Oncol 1:5–10.

    Google Scholar 

  218. Adelstein DJ, Rice TW, Becker M, Van Kirk MA, Kirby TJ, Doka A, Tefft M, Zuccaro. 1996. Concurrent chemotherapy (CCT), accelerated fractionation radiation (AFR) and surgery for esophageal cancer. Proc Am Soc Clin Oncol 15:203.

    Google Scholar 

  219. Posner MC, Landreneau RJ, Rosenstein MM, Clarke MR, Goodling WE, Lembersky BC. 1996. Preoperative chemoradiotherapy (CRT) for carcinoma of the esophagus (E) and gastroesophageal (GE) junction. Proc Am Soc Clin Oncol 15:209.

    Google Scholar 

  220. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. 1996. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14:156–163.

    PubMed  CAS  Google Scholar 

  221. Le Prise E, Etienne PL, Meunier B, Maddern G, Hassel MB, Gedouin D, Boutin D, Campion JP, Launois B. 1994. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73:1779–1784.

    PubMed  Google Scholar 

  222. Urba S, Orringer M, Turrisi A, Whyte R, Natale R, Iannettoni M, Forasteire A. 1995. A randomized trial comparing transhiatal esophagectomy to preoperative chemoradiation followed by esophagectomy in locoregional esophageal carcinoma. Proc Am Soc Clin Oncol 14:119.

    Google Scholar 

  223. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. 1996. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467.

    PubMed  CAS  Google Scholar 

  224. Bosset JF, Gignoux M, Triboulet JP, et al. 1994. Randomized phase III trial comparing surgery alone versus pre-operative combined radiochemotherapy in Stage I–II epidermoid cancer of the esophagus. Preliminary analysis. Proc Am Soc Clin Oncol 13:197.

    Google Scholar 

  225. Lishman AH, Dellipiani AW, Devlin HB. 1980. The insertion of oesophagastric tubes in malignant esophageal strictures: endoscopy or surgery. By J Surg 67:257–259.

    CAS  Google Scholar 

  226. Knyrim K, Wagner H-J, Bethge N, Keymling M, Wakil N. 1993. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 329:1302–1307.

    PubMed  CAS  Google Scholar 

  227. Cusumano A, Ruol A, Segalin A, Norberto L, Baessato M, Tiso E, Peracchia A. 1992. Pushthrough intubation: effective palliation in 409 patients with cancer of the esophagus and cardia. Ann Thorac Surg 53:1010–1014.

    PubMed  CAS  Google Scholar 

  228. Buset M, des Marez B, Baize M, Bourgeois N, de Boelpaepe C, de Toeuf J, Cremer M. 1987. Palliative endoscopic management of obstructive esophagogastric cancer: laser or prosthesis. Gastrointest Endosc 124:225–228.

    Google Scholar 

  229. Jensen DM, Machiado G, Randall G, Tung LA, English-Zych S. 1988. Comparison of lowpower YAG laser and BICAP tumor probe for palliation of esophageal cancer strictures. Gastroenterol 94:1267–1270.

    Google Scholar 

  230. Nava HR, Schuh ME, Nambisan R, Clark JL, Douglass HO Jr. 1989. Endoscopic ablation of esophageal malignancies with the neodynium-yag laser and electrofulguration. Arch Surg 124:225–228.

    PubMed  CAS  Google Scholar 

  231. Reed CE, Marsh WH, Carlson. 1991. Prospective randomized trial of palliative treatment for unresectable cancer of the esophagus. Ann Thorac Surg 51:552–556.

    PubMed  CAS  Google Scholar 

  232. Carter R, Smith JS, Anderson JR. 1992. Laser recanalization versus endoscopic intubation in the palliation of malignant dysphagia: a randomized prospective study. Br J Surg 79:1167–1170.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. William A. Flood
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arlene A. Forastiere
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Investigations Program Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, USA

    Al B. Benson III M.D., F.A.C.P. (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Flood, W.A., Forastiere, A.A. (1998). Esophageal cancer. In: Benson, A.B. (eds) Gastrointestinal Oncology. Cancer Treatment and Research, vol 98. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4977-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4977-2_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7259-2

  • Online ISBN: 978-1-4615-4977-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation